Skip to main content
AMMJ logo

American Cannabis Company, Inc. (AMMJ) Stock Price & Analysis

American Cannabis Company, Inc. (AMMJ) — price $0.0004 (0.00%), as of the Nov 19, 2026 trading session.

Educational signal · not a buy or sell recommendation · How to read this

$0.0004 $0.00 (0.00%)

American Cannabis Company, Inc. · AMMJ

American Cannabis Company, Inc. provides consulting services and products to businesses in the regulated cannabis and hemp industries in the United States and Canada. The company offers services from business planning to regulatory compliance, alongside cultivation products and equipment.

Price as of Nov 19, 2026

Key Statistics

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • THH · TryHard Holdings Limited · 28 /100
  • SST · System1, Inc. · 18 /100
  • PMEC · Primech Holdings Ltd. · 35 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$0.0004
Change on the day0.00%
52-week range$0.0001 – $0.00515
Shares traded on the day8.7K

Price & events

Other perspectives

Council score for American Cannabis Company (AMMJ): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Legends Council

4 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Unfavorable read

Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Negative
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Negative
ROE Negative
Gross Margin Moderate

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is American Cannabis Company (AMMJ), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. American Cannabis Company, Inc. (AMMJ) is the company analyzed here. It employs 4 people and is led by James Woodend. In Q2 FY2024 it reported revenue of $431,878 and net income of -$636,000.

2 · Latest results

What do the latest results show for American Cannabis Company (AMMJ)?

Short answer · as of

The most recent reported quarter, Q2 FY2024, carried revenue of $431,878.

Quarterly income statement — 2 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2024$431,878-$636,000-$0.0034 (diluted)
Q1 FY2024$255,821-$132,551-$0.0007 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for American Cannabis Company (AMMJ)?

Short answer · as of

The distress and quality screens read Altman Z -15.85 · Piotroski F 2. Trailing ratios: current ratio 0.42.

Data-derived red flags

  • Financial-distress signal — its Altman Z-Score of -15.85 sits in the distress zone (elevated bankruptcy risk).
  • Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.

The records behind this page

Insider activity

Form 4 records via FMP · Most recent available transactions

Transactions
12
Identified insiders
5
Purchases
0
Sales
1
Other transactions
11

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held AMMJ in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported AMMJ in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

American Cannabis Company Stock: Key Questions Answered

These answers are editorial: 1 of these 1 answer is drawn from the AMMJ research dossier (written Mar 16, 2026 by gemini-2.0-flash). Figures in this section are not part of the source register.

What are the main risks for AMMJ?

American Cannabis Company, Inc. faces several risks, including its small market capitalization, negative profit margin, and dependence on the evolving regulatory landscape of the cannabis industry. Increasing competition from larger consulting firms and cannabis companies poses a threat to its market share.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 13 figures on this page — 8 from Financial Modeling Prep (FMP) and 5 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.